Sanjiv S. Agarwala, MD
Professor of Medicine，Temple University School of Medicine, Chief, Oncology & Hematology
St. Luke’s Cancer Center, Easton, PA, USA
Dr. Agarwala is Chief of Medical Oncology & Hematology at St. Luke’s Cancer Center, Bethlehem, PA and Professor of Medicine at Temple University School of Medicine, Philadelphia, PA. He is nationally and internationally recognized as an expert in the research and treatment of melanoma and cutaneous malignancies. He graduated from the University of Bombay and did residencies and fellowships at the University of Bombay in India, Dunedin University in New Zealand and University of Pittsburgh in Pittsburgh, Pennsylvania.He has special interest and expertise in immunotherapy for cancer. He has been Principal Investigator for several clinical trials involving immunotherapy and targeted therapy for melanoma and other malignancies. He has over 100 publications and book chapters written on melanoma and other research areas. He is board certified in Oncology, Hematology and Internal Medicine and is an active member of several professional and scientific societies including the American Association for Cancer Research, the American Society of Clinical Oncology and the European Society of Medical Oncology and the Society for Melanoma Research.